Gilgamesh Pharma
New York, US · Founded 2025 · Delaware corporation · 35 employees on LinkedIn · 2 known investors
Find your way into Gilgamesh Pharma
761 people in our graph share verified history with the Gilgamesh Pharma team — schools, employers, funds. One of them is your warm intro.
Teresa Chanunlockedknows Jonathan Sporn · together at JNJ (overlapped)
×6knows the team · via Columbia University
knows the team · via JNJ
×3knows the team · via NIH
knows the team · via Columbia University in the City of New York
Founders & leadership
Gilgamesh Pharma was founded in 2025 by Andrew Kruegel and Jonathan Sporn.
AK
Andrew KruegelinCo-founder · Chief Scientific OfficerAndrew Kruegel is a medicinal chemist and neuroscientist who has worked on drug development, particularly for central nervous system disorders. He leads Gilgamesh Pharma as an executive officer and director.
JS
Jonathan SporninCo-founderBoard-certified psychiatrist trained at Tufts and Harvard with research experience in glutamate and mood disorders at Massachusetts General Hospital and the NIH intramural program; held drug development and portfolio strategy roles at Johnson & Johnson and Pfizer before founding Perception Neuroscience, which was acquired by ATAI Life Science, and currently serves as Executive Officer at Gilgamesh Pharmaceuticals.
Board
Investors · 2
Also in the syndicate · 1
Satori Neurolead
Reported raises · per SEC filings
Form D private placements$68.3M disclosed across 3 of 4 rounds · 2026
▶$2.3MraisedMar 2026 · 3 investors · PharmaceuticalsRule 506(b)
▶$2.3MraisedMar 2026 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Amy KruseDirector
- Jonathan SpornExecutive Officer, Director
- Phil SkolnickDirector
- Zia HuqueDirector
- Robert BermanDirector
- Andrew KruegelExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $2.3M
- Minimum investment
- $50K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
▶$60MraisedMar 2026 · 40 investors · PharmaceuticalsRule 506(b)
▶$60MraisedMar 2026 · 40 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Amy KruseDirector
- Zia HuqueDirector
- Robert BermanDirector
- Phil SkolnickDirector
- Jonathan SpornExecutive Officer, Director
- Andrew KruegelExecutive Officer, Director
- Offering amount
- $60M
- Amount sold
- $60M
- Minimum investment
- $50K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
▶$4.4MofferedFeb 2026 · 8 investors · PharmaceuticalsRule 506(b)
▶$4.4MofferedFeb 2026 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Phil SkolnickDirector
- Robert BermanDirector
- Zia HuqueDirector
- Amy KruseDirector
- Andrew KruegelExecutive Officer, Director
- Jonathan SpornExecutive Officer, Director
- Offering amount
- $4.4M
- Minimum investment
- $27
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
▶$6.1MraisedFeb 2026 · 9 investors · PharmaceuticalsRule 506(b)
▶$6.1MraisedFeb 2026 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Andrew KruegelExecutive Officer, Director
- Zia HuqueDirector
- Robert BermanDirector
- Phil SkolnickDirector
- Jonathan SpornExecutive Officer, Director
- Amy KruseDirector
- Offering amount
- $6.1M
- Amount sold
- $6.1M
- Minimum investment
- $27.6K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
The Gilgamesh Pharma mafia →7 people who came through Gilgamesh Pharma went on to found or lead other companies.
Dakin SlossInvestorFounded Tachyus +1Dakin SlossInvestorFounded Tachyus +1Tim SchlidtBoard ObserverFounded Palo SantoMolly LawrenceBoard ObserverFounded Palo SantoJonathan SpornExecutive Officer, DirectorFounded Gilgamesh PharmaceuticalsAndrew KruegelExecutive Officer, DirectorFounded Gilgamesh PharmaceuticalsDaniel UmbrichtHead of Clinical DevelopmentFounded Amporin
In the news
Frequently asked questions
- Who founded Gilgamesh Pharma?
- Gilgamesh Pharma was founded by Andrew Kruegel, Jonathan Sporn in 2025.
- Who are Gilgamesh Pharma's investors?
- Gilgamesh Pharma's investors include Prime Movers Lab.
- How much funding has Gilgamesh Pharma raised?
- Gilgamesh Pharma has disclosed $68.3M raised across 3 of its 4 known rounds.
- Where is Gilgamesh Pharma headquartered?
- Gilgamesh Pharma is headquartered in New York, US.